Jaguar Health (NASDAQ: JAGX) (“Jaguar”) is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, sustainably derived prescription medicines for people and animals with GI distress, including chronic, debilitating diarrhea. Napo Pharmaceuticals, a Jaguar company, focuses on developing and commercializing proprietary human pharmaceuticals from plants harvested responsibly from rainforest areas. Jaguar is the majority shareholder of Napo Therapeutics S.p.A., a corporation established by Jaguar in Italy in 2021 that focuses on expanding crofelemer access in Europe. Jaguar Animal Health is a tradename of Jaguar Health. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health, focuses on developing novel, natural prescription medicines derived from plants for mental health indications including attention-deficit/hyperactivity disorder (ADHD) in adults.For more information about Jaguar, please visit https://jaguar.health. For more information about Napo Pharmaceuticals, visit www.napopharma.com. For more information about Napo Therapeutics, visit napotherapeutics.com. For more information about Magdalena Biosciences, visit magdalenabiosciences.com.To read our full social media policy, please visit https://jaguar.health/social-media-policy
View Top Employees from Jaguar HealthWebsite | https://jaguar.health |
Ticker | JAGX |
Revenue | $5 million |
Funding | $9.5 million |
Employees | 43 (31 on RocketReach) |
Founded | 2013 |
Address | 200 Pine St Suite 400, San Francisco, California 94104, US |
Phone | (415) 371-8300 |
Technologies |
JavaScript,
HTML,
PHP
+23 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Drug Manufacturing & Research, Health Care, Naturally derived health solutions for companion and production , Nutraceutical, Other Healthcare, Healthcare, Pharmaceutical |
Competitors | Antibe Therapeutics Inc., Daré Bioscience, Inc., Piedmont Pharmaceuticals, Tonix Pharmaceuticals, Urigen Pharmaceuticals, Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541711 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular Jaguar Health employee's phone or email?
The Jaguar Health annual revenue was $5 million in 2024.
Ian Wendt is the Chief Commercial Officer of Jaguar Health.
31 people are employed at Jaguar Health.
Jaguar Health is based in San Francisco, California.
The NAICS codes for Jaguar Health are [54, 541711, 5417, 54171, 541].
The SIC codes for Jaguar Health are [283, 28].